Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu

Jacques De Greve; Erik Teugels; Johan De Mey; Caroline Geers; Lore Decoster; Pieter In 'T Veld; Denis Schallier; Martine Taton; Mehdi Shahidi

Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu

Jacques De Greve, Erik Teugels, Johan De Mey, Caroline Geers, Lore Decoster, Pieter In 'T Veld, Denis Schallier, Martine Taton, Mehdi Shahidi

Onderzoeksoutput: Editorial

Samenvatting

BIBW 2992

Originele taal-2	English
Pagina's (van-tot)	307-307
Aantal pagina's	1
Tijdschrift	Journal of Thoracic Oncology
Volume	4
Status	Published - 2009

Citeer dit

@article{1d157342d1ac4f18bf31a2c579ede261,

title = "Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu",

abstract = "BIBW 2992",

keywords = "adenocarcinoma, EGFR, HER2",

author = "{De Greve}, Jacques and Erik Teugels and {De Mey}, Johan and Caroline Geers and Lore Decoster and {In 'T Veld}, Pieter and Denis Schallier and Martine Taton and Mehdi Shahidi",

year = "2009",

language = "English",

volume = "4",

pages = "307--307",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

}

TY - JOUR

T1 - Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu

AU - De Greve, Jacques

AU - Teugels, Erik

AU - De Mey, Johan

AU - Geers, Caroline

AU - Decoster, Lore

AU - In 'T Veld, Pieter

AU - Schallier, Denis

AU - Taton, Martine

AU - Shahidi, Mehdi

PY - 2009

Y1 - 2009

N2 - BIBW 2992

AB - BIBW 2992

KW - adenocarcinoma

KW - EGFR

KW - HER2

M3 - Editorial

SN - 1556-0864

VL - 4

SP - 307

EP - 307

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

ER -

Clinical activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2 in adenocarcinoma of the lung with mutations in the kinase domain of HER2neu

Samenvatting

Vingerafdruk

Citeer dit